NERV EBITDA | Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc. (NERV) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$10.64M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$16.67M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$2.84M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$3.37M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2014-03-31 to 2020-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$10.64M	(m)	(m)	(m)	(m)	-$13.34M*	(m)	$7.19M	(m)	(m)
2026-03-31	Reported	(m)	-$16.67M	(m)	(m)	(m)	(m)	-$5.43M	(m)	$5.25M	(m)	(m)
2025-09-30	Reported	(m)	-$2.84M	(m)	(m)	(m)	(m)	-$2.92M*	(m)	$925.38K	(m)	(m)
2025-06-30	Reported	(m)	-$3.37M	(m)	(m)	(m)	(m)	-$2.04M*	(m)	$1.30M	(m)	(m)
2025-03-31	Reported	(m)	-$3.90M	(m)	(m)	(m)	(m)	-$4.07M	(m)	$1.36M	(m)	(m)
2024-09-30	Reported	(m)	-$4.37M	(m)	(m)	(m)	(m)	-$4.35M*	(m)	$1.89M	(m)	(m)
2024-06-30	Reported	(m)	-$6.28M	(m)	(m)	(m)	(m)	-$3.94M*	(m)	$3.86M	(m)	(m)
2024-03-31	Reported	(m)	-$6.68M	(m)	(m)	(m)	(m)	-$6.09M	(m)	$4.17M	(m)	(m)
2023-09-30	Reported	(m)	-$6.08M	(m)	(m)	(m)	(m)	-$4.81M*	(m)	$3.44M	(m)	(m)
2023-06-30	Reported	(m)	-$4.52M	(m)	(m)	(m)	(m)	-$3.87M*	(m)	$1.89M	(m)	(m)
2023-03-31	Reported	(m)	-$5.35M	(m)	(m)	(m)	(m)	-$115.41K	(m)	$2.65M	(m)	(m)
2022-09-30	Reported	(m)	-$5.21M	(m)	(m)	(m)	(m)	-$9.53M*	(m)	$2.37M	(m)	(m)
2022-06-30	Reported	(m)	-$6.97M	(m)	(m)	(m)	(m)	-$5.19M*	(m)	$4.13M	(m)	(m)
2022-03-31	Reported	(m)	-$7.99M	(m)	(m)	(m)	(m)	-$5.81M	(m)	$4.96M	(m)	(m)
2021-09-30	Reported	(m)	-$7.52M	(m)	$0.00*	(m)	(m)	-$8.63M*	(m)	$4.51M	(m)	(m)
2021-06-30	Reported	(m)	-$8.96M	(m)	$0.00*	(m)	(m)	-$5.92M*	(m)	$5.52M	(m)	(m)
2021-03-31	Reported	(m)	-$7.51M	(m)	$0.00	(m)	(m)	-$5.22M	(m)	$3.26M	(m)	(m)
2020-12-31	Reported	-$7.3M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$8.09M*	-$8.09M	$4.37K*	$0.00*	(m)	(m)	-$9.87M*	(m)	$4.64M	(m)	(m)
2020-06-30	Reported	$29.51M*	$29.51M	$4.37K*	$41.18M	71.67%*	(m)	-$7.59M*	(m)	$5.77M	(m)	(m)
2020-03-31	Reported	-$12.27M	(m)	(m)	(m)	(m)	(m)	-$9.20M	(m)	$8.08M	(m)	(m)
2019-12-31	Reported	-$32.36M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$14.28M*	-$14.28M	$4.37K*	$0.00*	(m)	(m)	-$9.52M*	(m)	$9.67M	(m)	(m)
2019-06-30	Reported	-$12.90M*	-$12.90M	$4.37K*	$0.00*	(m)	(m)	-$10.13M*	(m)	$8.32M	(m)	(m)
2019-03-31	Reported	-$16.31M	(m)	(m)	(m)	(m)	(m)	-$9.60M	(m)	$11.61M	(m)	(m)
2018-12-31	Reported	-$13.62M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$12.42M*	-$12.42M	$4.37K*	(m)	(m)	(m)	-$9.98M*	(m)	$8.37M	(m)	(m)
2018-06-30	Reported	-$12.93M*	-$12.94M	$4.37K*	(m)	(m)	(m)	-$11.23M*	(m)	$9.06M	(m)	(m)
2018-03-31	Reported	-$12.74M	(m)	(m)	(m)	(m)	(m)	-$10.93M	(m)	$8.45M	(m)	(m)
2017-12-31	Reported	-$9.53M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$11.40M*	-$11.41M	$2.71K*	(m)	(m)	(m)	$24.89M*	(m)	$8.96M	(m)	(m)
2017-06-30	Reported	-$9.74M*	-$9.75M	$3.30K*	(m)	(m)	(m)	(m)	(m)	$7.14M	(m)	(m)
2017-03-31	Reported	-$10.48M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$7.61M	(m)	(m)
2016-12-31	Reported	-$9.23M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$8.23M*	-$8.23M	$4.32K*	(m)	(m)	(m)	(m)	(m)	$5.85M	(m)	(m)
2016-06-30	Reported	-$4.96M*	-$4.96M	$4.32K*	(m)	(m)	(m)	(m)	(m)	$2.71M	(m)	(m)
2016-03-31	Reported	-$7.75M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$5.37M	(m)	(m)
2015-12-31	Reported	-$8.19M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$5.70M*	-$5.71M	$4.32K*	(m)	(m)	(m)	(m)	(m)	$3.83M	(m)	(m)
2015-06-30	Reported	-$6.33M*	-$6.33M	-$1.07K*	(m)	(m)	(m)	(m)	(m)	$4.48M	(m)	(m)
2015-03-31	Reported	-$5.87M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$3.96M	(m)	(m)
2014-12-31	Reported	-$7.44M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$27.13M*	-$27.15M	$25.61K*	(m)	(m)	(m)	(m)	(m)	$24.74M	(m)	$0.00
2014-06-30	Reported	-$17.65M*	-$17.65M	$4.00K*	(m)	(m)	(m)	(m)	(m)	$14.55M	(m)	$0.00
2014-03-31	Reported	-$2.62M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$585.94K	(m)	(m)
2013-12-31	Reported	(m)	-$2.04M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	(m)	-$482.00K	(m)	(m)	(m)	(m)	(m)	(m)	$190.66K	(m)	$0.00
2013-06-30	Reported	(m)	-$379.00K	(m)	(m)	(m)	(m)	(m)	(m)	$249.84K	(m)	$0.00
2013-03-31	Reported	(m)	-$271.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$15.10M	(m)	(m)	(m)	(m)	-$13.51M	(m)	$5.76M	(m)	(m)
2024-12-31	Reported	(m)	-$21.85M	(m)	$0.00	(m)	(m)	-$19.55M	(m)	$11.90M	(m)	(m)
2023-12-31	Reported	(m)	-$23.12M	(m)	$0.00	(m)	(m)	-$14.78M	(m)	$12.71M	(m)	(m)
2022-12-31	Reported	(m)	-$25.23M	(m)	$0.00	(m)	$16.33K	-$24.65M	(m)	$14.65M	(m)	(m)
2021-12-31	Reported	(m)	-$45.37M	(m)	$0.00	(m)	(m)	-$24.60M	(m)	$32.04M	(m)	-$1.80M
2021-09-30	Rolling	(m)	-$31.29M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	Rolling	(m)	-$31.86M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Rolling	(m)	$6.61M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	$1.86M	(m)	(m)	(m)	(m)	(m)	-$33.82M	(m)	$22.04M	(m)	(m)
2020-12-31	Rolling	(m)	$1.85M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Rolling	(m)	-$23.22M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$29.41M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$71.82M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	-$75.85M	(m)	(m)	(m)	(m)	(m)	-$43.43M	(m)	$58.12M	(m)	-$2.25M
2019-12-31	Rolling	(m)	-$75.86M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$57.13M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$55.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$55.30M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	-$51.71M	(m)	(m)	(m)	(m)	(m)	-$41.94M	(m)	$34.89M	(m)	$0.00
2018-12-31	Rolling	(m)	-$51.73M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$47.63M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$46.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$43.43M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	-$41.16M	(m)	(m)	(m)	(m)	$52.40K	$3.09M	(m)	$30.26M	(m)	-$9.40M
2017-12-31	Rolling	(m)	-$41.17M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$40.88M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$37.70M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$32.92M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	-$30.17M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$20.44M	(m)	$0.00
2016-12-31	Rolling	(m)	-$30.19M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$29.15M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$26.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$27.99M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	-$26.09M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$18.53M	(m)	$0.00
2015-12-31	Rolling	(m)	-$26.11M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$25.36M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$46.81M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	-$58.13M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$54.84M	(m)	(m)	(m)	(m)	$45.61K	(m)	(m)	$42.91M	(m)	(m)
2014-12-31	Rolling	(m)	-$54.87M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	-$49.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	Rolling	(m)	-$22.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Rolling	(m)	-$5.53M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	(m)	-$3.17M	(m)	(m)	(m)	$3.23K	(m)	(m)	$708.49K	(m)	(m)
2013-12-31	Rolling	(m)	-$3.17M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Tonix Pharmaceuticals Holding Corp. (TNXP)	United States	$0.166B	-1.34
ADC Therapeutics SA (ADCT)		$0.163B	-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)	United States	$0.163B	-8.50
Organogenesis Holdings Inc. (ORGO)	United States	$0.182B	-3.70
Annexon, Inc. (ANNX)	United States	$0.147B	-4.22
AN2 Therapeutics, Inc. (ANTX)	United States	$0.185B	-4.84
PepGen Inc. (PEPG)	United States	$0.186B	-1.73
Corbus Pharmaceuticals Holdings, Inc. (CRBP)	United States	$0.144B	-1.72
ALX ONCOLOGY HOLDINGS INC (ALXO)	United States	$0.187B	-3.52
Fortress Biotech, Inc. (FBIO)	United States	$0.188B	0.91